Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B

Written by Heather Linder | January 17, 2014 | Print  |

Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson's ortho-clinical testing business for $4.15 billion, according to a Mass Device report.The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.

More Articles on Devices:

Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months